Literature DB >> 2679638

The role of interleukin 2 in autoimmunity.

G Kroemer, G Wick.   

Abstract

In addition to playing a major role in physiological immune responses against foreign antigens, the interleukin 2 (IL-2)-IL-2 receptor (IL-2R) system may also be implicated in autoimmune phenomena. Initial studies on the role of IL-2 in autoimmunity indicate a deficiency in the production of this lymphokine in autoimmune disease. Here, Guido Kroemer and Georg Wick review recent data supporting the notion that an excess of endogenous or exogenous IL-2 may aggravate autoaggression by triggering autoreactive effector cells, and they speculate that IL-2 might favor the de novo development of autoimmunity by breaking autotolerance.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2679638     DOI: 10.1016/0167-5699(89)90262-4

Source DB:  PubMed          Journal:  Immunol Today        ISSN: 0167-5699


  13 in total

Review 1.  Current status and challenges of cytokine pharmacology.

Authors:  Z Zídek; P Anzenbacher; E Kmonícková
Journal:  Br J Pharmacol       Date:  2009-04-03       Impact factor: 8.739

Review 2.  Transgenic mice in the study of cytokine function.

Authors:  J Taverne
Journal:  Int J Exp Pathol       Date:  1993-12       Impact factor: 1.925

Review 3.  Lymphocyte and macrophage interleukin receptors in inflammatory bowel disease: a more selective target for therapy?

Authors:  M J Weldon; J D Maxwell
Journal:  Gut       Date:  1994-07       Impact factor: 23.059

4.  Dexamethasone inhibits human interleukin 2 but not interleukin 2 receptor gene expression in vitro at the level of nuclear transcription.

Authors:  D T Boumpas; E D Anastassiou; S A Older; G C Tsokos; D L Nelson; J E Balow
Journal:  J Clin Invest       Date:  1991-05       Impact factor: 14.808

5.  Cytokines in sera from insulin-dependent diabetic patients at diagnosis.

Authors:  M G Cavallo; P Pozzilli; C Bird; M Wadhwa; A Meager; N Visalli; A J Gearing; D Andreani; R Thorpe
Journal:  Clin Exp Immunol       Date:  1991-11       Impact factor: 4.330

6.  Interleukin 2 production in a family with systemic lupus erythematosus and a C4Q0 heterozygous inheritance.

Authors:  C Gutierrez; E Cabrero; J L Vicario; M Martín Villa; M A Rengel; F J Gomez Campdera; M Yebra; E Fernández-Cruz; A Arnaiz Villena
Journal:  Ann Rheum Dis       Date:  1991-08       Impact factor: 19.103

Review 7.  Cytokines and autoimmunity.

Authors:  M G Cavallo; P Pozzilli; R Thorpe
Journal:  Clin Exp Immunol       Date:  1994-04       Impact factor: 4.330

8.  B7/BB1 provides an important costimulatory signal for CD3-mediated T lymphocyte proliferation in patients with systemic lupus erythematosus (SLE).

Authors:  P P Sfikakis; R Oglesby; P Sfikakis; G C Tsokos
Journal:  Clin Exp Immunol       Date:  1994-04       Impact factor: 4.330

9.  Prevention of cyclophosphamide-induced diabetes in the NOD/WEHI mouse with deoxyspergualin.

Authors:  F Nicoletti; M O Borghi; P L Meroni; W Barcellini; C Fain; R Di Marco; R Menta; H U Schorlemmer; G Bruno; G Magro
Journal:  Clin Exp Immunol       Date:  1993-02       Impact factor: 4.330

10.  Lymphokines and soluble interleukin-2 receptors in juvenile chronic arthritis. Clinical and laboratory correlations.

Authors:  K Müller; F K Pedersen; A Wiik; K Bendtzen
Journal:  Rheumatol Int       Date:  1992       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.